Impact of COVID-19 on Metabolic Parameters in Patients with Type 2 Diabetes Mellitus
Authors:
Preprint
- 11 November 2024
- preprint
- Published by Springer Nature in Research Square
Abstract
Background and aim Since the onset of the Coronavirus disease 2019 (COVID-19) pandemic, individuals with Type 2 diabetes mellitus (T2DM) have been one of the most susceptible populations to contracting the virus. Also, COVID-19 and its related lockdown restrictions have affected metabolic regulatory mechanisms within the T2DM population. The present study aims to determine the impact of the viral infection and its lockdown on the physiological parameters in individuals with T2DM. Methods: In this retrospective cohort study, the medical records of 118 individuals with prior diagnoses of T2DM were collected. All the subjects had undergone at least one laboratory test within a maximum of three months before the onset of the COVID-19 pandemic in Iran. Fifty-nine patients with a confirmed COVID-19 infection within the first three months of the pandemic underwent a follow-up lab test six months after their initial COVID-19 diagnosis. The individuals without a history of the infection underwent a follow-up lab test six months after the onset of the pandemic. Noninfected populations were matched for age and gender with infected patients. Comparative analysis of clinical and laboratory data within each group was conducted. Results: The ‘COVID-19 positive’ group exhibited a significant decrease in levels of triglycerides (TG) (P = 0.001) and total cholesterol (TC) (P = 0.028), body mass index (BMI) (P = 0.034), atherogenic index of plasma (AIP) (P = 0.027), triglyceride glucose (TyG) index (P = 0.001), and triglyceride glucose -BMI (TyG-BMI) index (P < 0.001) during the first six months post-infection compared to pre-pandemic. Other variables did not show notable changes. The ‘COVID-19 negative’ group had a significant reduction in TC (P = 0.001) and low-density lipoprotein cholesterol (LDL-C) (P = 0.01). Conclusion: Individuals with T2DM and mild to moderate COVID-19 infection experienced an improvement in the levels of TC, TG, BMI, and insulin-related indices. Restrictions in the first lockdown were associated with a decrease in the levels of TC and LDL-C in the T2DM population who did not have a history of the viral infection.Keywords
All Related Versions
- Version 1, 2024-11-11, Research Square
- Published version: BMC Pulmonary Medicine, 25 (1), 1.
This publication has 44 references indexed in Scilit:
- Malnutrition in COVID-19 survivors: prevalence and risk factorsAging Clinical and Experimental Research, 2023
- Connecting the dots between inflammatory cascades of obesity and COVID-19 in light of mortal consequences—a reviewEnvironmental Science and Pollution Research, 2022
- Impact of diabetes on COVID‐19 mortality and hospital outcomes from a global perspective: An umbrella systematic review and meta‐analysisEndocrinology, Diabetes & Metabolism, 2022
- The impact of COVID-19 pandemic on glycemic control in patients with diabetes mellitus in Turkey: a multi-center study from KocaeliJournal of Diabetes & Metabolic Disorders, 2021
- SARS-CoV-2 infection induces beta cell transdifferentiationCell Metabolism, 2021
- A meta-analysis of comorbidities in COVID-19: Which diseases increase the susceptibility of SARS-CoV-2 infection?Computers in Biology and Medicine, 2021
- Improved glycemic control amongst people with long-standing diabetes during COVID-19 lockdown: a prospective, observational, nested cohort studyInternational Journal of Diabetes in Developing Countries, 2020
- Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th editionDiabetes Research and Clinical Practice, 2019
- Dietary fibre for the primary prevention of cardiovascular disease2015
- Dietary advice for reducing cardiovascular risk2013